Individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit a wide range of clinical alterations, from asymptomatic infection to fatal disease. In a recent...
recently Nature Communications Journal, Researchers determine rate of thrombosis, thrombocytopenia, and thrombocytopenia with thrombocytopenia after vaccination and infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
On March 11, 2020, the World Health Organization (WHO) announced the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19)....
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), continues to evolve through genomic mutation. Emerging SARS-CoV-2 variants are classified...
In a recent study posted on medrex sib*Preprint server, investigators evaluated the immunogenicity and safety of a fourth allogeneic boost dose of recombinant severe acute respiratory...
A recent study published in the journal BMCmedicineresearchers estimated the prevalence of new-onset diabetes following coronavirus disease 2019 (COVID-19). Despite numerous vaccines and antiviral treatments against...
Recent Comments